ABL Diagnostics to acquire TEXCELL

PARIS: ABL Diagnostics, a molecular diagnostics and healthcare software company listed on Euronext Paris, has been selected by the Évry Commercial Court to acquire the assets and operations of TEXCELL, the company announced. The court approved ABL Diagnostics’ plan following the submission of…